Sablich Kim 4
4 · Jazz Pharmaceuticals plc · Filed Nov 15, 2021
Insider Transaction Report
Form 4
Sablich Kim
EVP & GM, North America
Transactions
- Sale
Ordinary Shares
2021-11-11$135.01/sh−2,748$371,000→ 21,135 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.